REG - Dr. Martens PLC - Chief Brand Officer Appointment

Dr MartensAnnouncement

16/11/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231116:nRSP6029Ta&default-theme=true

RNS Number : 6029T  Dr. Martens PLC  16 November 2023

16 November 2023

Dr. Martens plc

 

Creation of Chief Brand Officer role

Ije Nwokorie appointed into new role and will step down as Non-Executive
Director as a result

 

Dr. Martens plc announces that Non-Executive Director Ije Nwokorie will join
as Chief Brand Officer from 1(st) February 2024. On appointment into this
role, Ije will cease to be a member of the Board and will step down as a
member of the Audit and Risk, Nomination and Disclosure committees.

The newly-created role of Chief Brand Officer will be a key member of the
global leadership team, reporting into Kenny Wilson, CEO, overseeing the
Global Marketing, Product and Strategy functions. The Chief Brand Officer will
be responsible for setting the overall brand strategy, vision and direction
for the next phase of Dr. Martens' growth.

Ije will join Dr. Martens as Chief Brand Officer from Apple Inc, where he has
been Senior Director, Apple Retail since January 2018. Prior to this he spent
11 years at global brand consultancy Wolff Olins, where he was latterly CEO,
leading teams in offices in San Francisco, London, Dubai and New York. He is
currently also Chair of non-profit organisation charity: water UK.

Paul Mason, Chair, said "Ije has been a tremendous Non-Executive Director
since he joined the Board in January 2021. He has deep insight and
understanding of brands and has extensive global DTC experience. I am
delighted that he'll be joining the leadership team as Chief Brand Officer, a
role for which he is perfectly suited."

Kenny Wilson, CEO, said "Ije is a visionary brand storyteller and this, along
with his infectious passion for Dr. Martens, makes him the ideal person to
lead the next era of our brand development. I am delighted that he will be
joining my team in a permanent full-time position of Chief Brand Officer,
which will be a crucial role to enable us to become a £2bn revenue brand."

Ije Nwokorie said "I've always loved Dr. Martens and it's been a real
privilege getting to know the brand from the inside as a Non-Executive
Director. Dr. Martens is defined by its rebellious, authentic and creative
nature, all of which makes me really excited to be joining Kenny and the team
early in the new year and to get to work."

 

Enquiries

Investors and analysts

Bethany Barnes, Director of Investor Relations
Bethany.Barnes@drmartens.com    +44 7825 187465

Beth Callum, Senior Investor Relations Analyst
Beth.Callum@drmartens.com  +44 203 995 2644

 

Press
 

H/Advisors Maitland
                     +44 207 379 5151

   Clinton Manning
                                +44 7711 972662

 

Gill Hammond, Director of Communications             +44 7384 214248

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Produced originally for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DM's"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude. The Company is a constituent of the FTSE
250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNBLBDBGUBDGXU